Search
Now showing items 1-5 of 5
“If donors woke up tomorrow and said we can't fund you, what would we do?” A health system dynamics analysis of implementation of PMTCT option B+ in Uganda.
(BioMed Central, 2017)
BACKGROUND: In October 2012 Uganda extended its prevention of mother to child HIV transmission (PMTCT) policy
to Option B+, providing lifelong antiretroviral treatment for HIV positive pregnant and breastfeeding women. ...
Correction to: Effects of early feeding on growth velocity and overweight/obesity in a cohort of HIV unexposed South African infants and children
(BioMed Central, 2017)
After publication of this article [1] it was brought to our attention
that there were errors in the text under the heading
‘Data cleaning’, and in Table 3. The corrected text and updated
Table 3 are given in this erratum.
Which new health technologies do we need to achieve an end to HIV/AIDS?
(Public Library of Science, 2016)
In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful lifesaving
development of medical research. Antiretrovirals (ARVs) are used with great success
for both the treatment and prevention ...
In utero art exposure and birth and early growth outcomes among HIV-exposed uninfected infants attending immunization services: Results from national pmtct surveillance, South Africa
(Oxford University Press, 2017)
. Despite the recognized benefit of antiretroviral therapy (ART) for preventing and treating HIV, some studies have
reported adverse birth outcomes with in utero ART exposure. We evaluated the effect of infant in utero ...
Eliminating mother to child HIV transmission in South Africa
(World Health Organization (WHO), 2013)
PROBLEM: The World Health Organization has produced clear guidelines for the prevention of mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV). However, ensuring that all PMTCT programme components ...